Bristol-Myers Squibb expands R&D presence in the US
25 June 2015 | By Victoria White
Bristol-Myers Squibb Company has announced important next steps in the evolution of the Company’s R&D organisation...
List view / Grid view
News
ViraTherapeutics raises €3.6 million to advance its lead product VSV-GP
24 June 2015 | By Victoria White
ViraTherapeutics has announced the first closing of a Series A financing round, raising €3.6 million that it will use to advance its lead product VSV-GP...
Sandoz to speak on their first Biosimilar approved by the FDA at Biosimilars & Biobetters USA in Iselin
24 June 2015 | By Biosimilars and Biobetters
SMi Group reports (2015.06.23 – Iselin, New Jersey, USA): John Pakulski, Head US Biopharmaceutical Regulatory Affairs, Sandoz, will be presenting on Day of the SMi’s Biosimilars & Biobetters USA conference in Iselin (16th-17th November 2015). Registration to the event is now open...
Novogen’s Anisina on track to enter the clinic in 2016
24 June 2015 | By Victoria White
Novogen has announced that its candidate cytotoxic chemotherapy drug, Anisina, has proved an effective anti-cancer agent in animals...
Scientists discover blood protein that may indicate risk of Alzheimer’s
24 June 2015 | By Victoria White
Scientists have identified a single blood protein that may indicate the development a disorder associated with an increased risk of Alzheimer's disease...
Study demonstrates how Huntington’s disease proteins spread from cell to cell
24 June 2015 | By Victoria White
A new study, led by scientists at UC Irvine, demonstrates how Huntington's disease proteins spread from cell to cell and could lead to new treatments...
AYOXXA and Grünenthal complete research collaboration
24 June 2015 | By Victoria White
AYOXXA and Grünenthal have completed a research collaboration to validate detection limits for a biomarker based on AYOXXA’s proprietary technology platform...
Purdue researchers successfully target ‘Achilles’ heel’ of MERS virus
23 June 2015 | By Victoria White
Researchers studying MERS have found molecules that shut down the activity of an essential enzyme in the virus that could lead to a treatment for the virus...
Smart insulin patch could make painful injections a thing of the past for diabetes sufferers
23 June 2015 | By Victoria White
Researchers have created the first smart insulin patch that can detect increases in blood sugar levels and secrete doses of insulin into the bloodstream...
Blueprint Medicines announces first preclinical data for BLU6864
23 June 2015 | By Victoria White
Blueprint Medicines has announced the first preclinical data for its drug candidate BLU6864, a RET-specific kinase inhibitor.
Reactivating happy memories can cure the symptoms of depression
22 June 2015 | By Victoria White
MIT neuroscientists have shown that they can cure the symptoms of depression in mice by artificially reactivating happy memories...
HIV vaccine research generates key antibodies in animal models
22 June 2015 | By Victoria White
New studies have demonstrated techniques for stimulating animal cells to produce antibodies that could stop HIV from infecting human cells in the laboratory...
PSMA-617 can be used to irradiate prostate cancer cells from the inside
22 June 2015 | By Victoria White
Scientists at the German Cancer Research Centre have developed an agent, PSMA-617, which is capable of attaching specifically to prostate cancer cells...
MERS-CoV candidate vaccine gears up for clinical trials
22 June 2015 | By Victoria White
Researchers from LMU have demonstrated the protective effect of a candidate vaccine directed against MERS-CoV in preclinical studies...
Brain inflammation targeted in first Dementia Consortium drug discovery project
22 June 2015 | By Victoria White
The Dementia Consortium is funding a new project to target the immune system in the hunt for new treatments for Alzheimer's disease...
